Active Ingredient History
Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory drug that exhibits antiinflammatory, analgesic, and antipyretic activities in animal models. Flurbiprofen Tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and for relief of the signs and symptoms of osteoarthritis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Similar to other NSAIAs, the anti-inflammatory effect of flurbiprofen occurs via reversible inhibition of cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This effectively decreases the concentration of prostaglandins involved in inflammation, pain, swelling and fever. Flurbiprofen is a non-selective COX inhibitor and inhibits the activity of both COX-1 and -2. It is also one of the most potent NSAIAs in terms of prostaglandin inhibitory activity. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Pain (Phase 4)
Analgesia (Phase 1)
Analgesia, Patient-Controlled (Phase 4)
Analgesics, Opioid (Phase 2/Phase 3)
Anemia (Phase 1)
Anemia, Sickle Cell (Phase 1)
Anti-Inflammatory Agents, Non-Steroidal (Phase 2/Phase 3)
Arthritis, Rheumatoid (Phase 1)
Back Pain (Phase 2)
Bone and Bones (Phase 1)
Bone Resorption (Phase 1)
Conscious Sedation (Phase 4)
Cough (Early Phase 1)
Drug Interactions (Phase 1)
Drugs, Investigational (Phase 4)
Esophageal Neoplasms (Phase 2/Phase 3)
Fractures, Stress (Phase 1)
General Surgery (Phase 2/Phase 3)
Healthy Volunteers (Phase 1/Phase 2)
HIV (Phase 1)
HIV Infections (Phase 4)
Leukemia, Myeloid, Acute (Phase 1)
Midazolam (Phase 4)
Mitochondrial Diseases (Phase 1)
Mucositis (Early Phase 1)
Pain (Phase 4)
Pain, Postoperative (Phase 4)
Pancreatic Diseases (Phase 4)
Periodontitis (Phase 4)
Pharmacology (Phase 1)
Pharyngitis (Phase 3)
Postoperative Complications (Phase 1)
Pruritus (Phase 2)
Quality of Life (Phase 4)
Respiratory Tract Infections (Early Phase 1)
Sleep Disorders, Intrinsic (Phase 1)
Surgery, Oral (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
